Allstar Health Brands, Inc. (ALST)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Allstar Health Brands, Inc. (ALST) trades at $0.00 with AI Score 43/100 (Grade C). Allstar Health Brands, Inc. is a specialty healthcare products company offering medicines, natural nutritional supplements, and OTC remedies in the Americas. Market cap: $6,759, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for ALST: ALST does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ALST against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ALST: the 1 perspectives are evenly split.
How is this calculated? →Allstar Health Brands, Inc. (ALST) Healthcare & Pipeline Overview
Allstar Health Brands, Inc. is a Canadian-headquartered specialty healthcare products company established in 1997, distributing select medicines, natural nutritional supplements, and over-the-counter remedies across the Americas. The company leverages a Tapout license for globally branded nutraceuticals, including pain relief products, through a marketing partnership with World Wide Entertainment (WWE).
What Is the Investment Thesis for ALST?
Allstar Health Brands, Inc. operates within the health and wellness sector, focusing on the distribution of specialty healthcare products, including natural nutritional supplements and OTC remedies across the Americas. A key value driver for the company is its exclusive Tapout license for globally branded nutraceutical products, such as pain relief sprays and wipes, coupled with a strategic marketing partnership with World Wide Entertainment (WWE). These assets provide a foundation for potential growth by leveraging established brand recognition and broad marketing channels to capitalize on the ongoing consumer interest in health and wellness products. However, the investment profile is significantly influenced by substantial risks. The company trades on the OTC Other tier with an extremely low market capitalization of 7K (approximately $5,069) and a share price of $0.0003, indicating significant financial risk and potential liquidity challenges. Furthermore, its disclosure status is unknown, limiting investor access to critical financial and operational information. Investors must consider these factors, alongside the company's negative Beta of -0.41, when evaluating its potential.
Based on FMP financials and quantitative analysis
ALST Key Highlights
- Market Capitalization: $0.00B, reflecting an extremely low valuation within the broader healthcare sector.
- Beta: -0.41, suggesting a historical tendency for the stock to move inversely to the overall market.
- Dividend Policy: The company does not currently pay a dividend, consistent with its operational stage and capital allocation strategy.
- Operational Scale: Allstar Health Brands, Inc. operates with a lean team of 4 employees, headquartered in Toronto, Canada.
- Market Listing: Trades on the OTC Other tier, characterized by limited public disclosure and potentially lower liquidity compared to major stock exchanges.
Who Are ALST's Competitors?
ALST is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company | $4.88 | -5.97% | $1.80B | 68 |
| MEDS TRxADE HEALTH, Inc. | $7.59 | +4.55% | $13.28M | 63 |
| ONC BeOne Medicines Ltd. | $309.46 | +3.97% | $33.07B | 61 |
| NEUP Neuphoria Therapeutics Inc. | $3.44 | +1.78% | $18.59M | 60 |
| YI 111, Inc. | $4.13 | -0.12% | $36.04M | 44 |
| ALBHF Alibaba Health Information Technology Limited | $0.42 | +2.44% | $6.77B | 45 |
| WBA Walgreens Boots Alliance operates as a pharmacy-led health and beauty retail company with a global presence. The company | $11.98 | +0.50% | $10.37B | 45 |
| IPXL Impax Laboratories, Inc. | $18.30 | +0.55% | 46 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ALST's Key Strengths?
- Exclusive Tapout brand license for globally branded nutraceutical products.
- Strategic marketing and sales partnership with World Wide Entertainment (WWE).
- Established presence in the healthcare sector since its founding in 1997.
- Focus on the growing consumer interest in health and wellness products.
What Are ALST's Weaknesses?
- Extremely low market capitalization of 7K, indicating significant financial risk.
- Trades on the OTC Other tier with an unknown disclosure status, limiting transparency.
- Market position and key product lines are not clearly defined based on available information.
- Lean operational structure with only 4 employees, potentially limiting scalability and resources.
What Could Drive ALST Stock Higher?
- Growing consumer interest in health and wellness products, providing a favorable market backdrop for the company's offerings.
- Leveraging the Tapout brand license for nutraceutical product sales, utilizing an established brand for market penetration.
- Marketing and sales activities through the World Wide Entertainment (WWE) partnership, enhancing product visibility and reach.
- Potential expansion of product lines under the Tapout license, introducing new nutraceuticals or OTC remedies.
- Any future operational updates or financial disclosures that could provide greater transparency to investors, should the company improve its reporting.
What Are the Key Risks for ALST?
- Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Significant financial risk due to an extremely low market capitalization of 7K and a share price of $0.0003.
- Lack of transparency and limited disclosure stemming from its OTC Other tier listing and 'Unknown' disclosure status.
- High operational risk given the small employee count of 4, potentially limiting capacity for growth and compliance management.
- Inability to maintain regulatory compliance within the complex and evolving medical and pharmaceutical product industries.
- Challenges in clearly defining and effectively establishing its market position and key product lines amidst intense competition.
What Are the Growth Opportunities for ALST?
- Leveraging the Tapout Brand Expansion: Allstar Health Brands, Inc. possesses the Tapout license for globally branded nutraceutical products, a significant asset in the health and wellness sector. This opportunity involves expanding the current Tapout product line beyond pain relief sprays and wipes to include a wider array of nutritional supplements, vitamins, or other over-the-counter remedies. The Tapout brand, being "globally branded," carries inherent recognition that can facilitate market entry for new products. By strategically introducing new offerings under this established brand, the company could capture a larger share of the growing nutraceutical market. The timeline for such expansion would depend on product development, regulatory approvals, and market launch strategies, potentially unfolding over the next 1-3 years.
- Strengthening the WWE Marketing Partnership: The existing partnership with World Wide Entertainment (WWE) for marketing Tapout nutraceutical products presents a substantial growth avenue. This opportunity involves deepening the collaboration to explore new marketing channels, co-branded initiatives, or expanded promotional campaigns that leverage WWE's vast audience and media reach. By optimizing this partnership, Allstar Health Brands could significantly enhance brand visibility and consumer engagement for its Tapout line, potentially translating into increased sales volumes. Effective utilization of this partnership could yield results within a 12-24 month timeframe, depending on the scope and intensity of joint marketing efforts.
- Capitalizing on Growing Health & Wellness Trends: The broader market for natural nutritional supplements and over-the-counter remedies is experiencing sustained growth due to increasing consumer awareness of preventative health and a preference for self-care solutions. Allstar Health Brands, Inc.'s focus on these product categories positions it to benefit from these overarching trends. The opportunity lies in continuously monitoring market demands and adapting its product portfolio to align with emerging health trends, such as demand for specific vitamins, immune support, or specialized dietary supplements. This ongoing trend provides a foundational tailwind for the company's product offerings over the long term, typically a 3-5 year horizon.
- Geographic Expansion within the Americas: While Allstar Health Brands currently operates across "the Americas," there is potential for more focused or deeper penetration into specific regional markets within this broad geographic scope. This opportunity involves identifying underserved areas or markets with high demand for specialty healthcare products, natural supplements, and OTC remedies. By tailoring distribution strategies and marketing efforts to specific countries or regions, the company could expand its customer base and increase market share. Such expansion would require market research, regulatory navigation, and establishing local distribution networks, a process that could span 2-4 years.
- Product Diversification Beyond Current Offerings: Beyond expanding the Tapout brand, a broader growth opportunity exists in diversifying the company's overall product portfolio to include other specialty medicines or innovative health solutions. This could involve licensing additional brands, developing proprietary formulations, or acquiring complementary product lines that align with its mission of enhancing health and quality of life. Such diversification would reduce reliance on a single brand or product category and open new revenue streams. This strategy would typically involve longer-term planning, potentially 3-5 years, given the research, development, and regulatory hurdles inherent in the medical and pharmaceutical industries.
What Opportunities Does ALST Have?
- Potential to expand the Tapout product line beyond current pain relief offerings.
- Deepening the marketing and sales collaboration with WWE to reach broader audiences.
- Capitalizing on the sustained growth and consumer demand in the natural nutritional supplements market.
- Strategic geographic expansion or deeper penetration within specific regions of the Americas.
What Threats Does ALST Face?
- Intense competition within the highly fragmented health and wellness and nutraceutical markets.
- Regulatory compliance risks inherent in the medical and pharmaceutical product industries.
- Significant liquidity issues and price volatility due to its OTC Other listing and micro-cap status.
- Potential for brand dilution or termination of key partnerships, such as the Tapout license or WWE agreement.
What Are ALST's Competitive Advantages?
- Exclusive Tapout brand license for nutraceutical products, providing a recognized brand for market entry.
- Strategic marketing and sales partnership with World Wide Entertainment (WWE), offering broad promotional reach.
- Established operational history since 1997, indicating longevity in the healthcare sector.
- Focused niche within the health and wellness sector, targeting specific consumer needs with specialty products.
- Geographic focus across the Americas, allowing for targeted market penetration and distribution strategies.
What Does ALST Do?
Allstar Health Brands, Inc., a specialty healthcare products company headquartered in Toronto, Canada, has been operating since its founding in 1997. Initially known as Axxess Pharma, Inc., the company underwent a name change to Allstar Health Brands, Inc. in June 2017, reflecting an evolution in its strategic focus. The company's core mission revolves around enhancing health and quality of life by offering a curated portfolio of select medicines, natural nutritional supplements, and over-the-counter (OTC) remedies. Its operational footprint is primarily concentrated across the Americas, aiming to cater to the diverse health and wellness needs of consumers in these regions. A significant component of Allstar Health Brands' business model is its strategic licensing agreements and partnerships. The company holds the exclusive Tapout license, enabling it to market and sell globally branded nutraceutical products. This portfolio notably includes pain relief sprays and wipes, which are positioned to address consumer demand for accessible and effective self-care solutions. To amplify the reach and market penetration of these Tapout-branded nutraceuticals, Allstar Health Brands, Inc. has forged a partnership with World Wide Entertainment (WWE). This collaboration is designed to leverage WWE's extensive global brand recognition and marketing channels to promote and distribute the Tapout line of products, particularly within the health and wellness segment that aligns with the WWE audience demographic. While the company reportedly focuses on developing and distributing nutritional supplements, the specific market position and the full breadth of its key product lines are not extensively detailed in available information. However, its stated commitment to natural nutritional supplements and OTC remedies positions it within the broader health and wellness sector, a market characterized by growing consumer interest in preventative health and self-medication trends. The company's lean operational structure, with only four employees, suggests a focused approach to its niche market segments within the healthcare industry.
What Products and Services Does ALST Offer?
- Offers a portfolio of specialty healthcare products.
- Distributes select medicines to consumers.
- Provides natural nutritional supplements.
- Sells a range of over-the-counter (OTC) remedies.
- Operates and distributes products across the Americas.
- Holds the exclusive Tapout license for nutraceutical products.
- Markets globally branded nutraceuticals, including pain relief sprays and wipes.
- Partners with World Wide Entertainment (WWE) for marketing and sales of Tapout nutraceuticals.
How Does ALST Make Money?
- Generates revenue through the sale of licensed Tapout-branded nutraceutical products.
- Earns income from the distribution and sale of select medicines.
- Derives revenue from the sale of natural nutritional supplements.
- Sells over-the-counter remedies to consumers in the Americas.
- Leverages strategic partnerships, particularly with WWE, to enhance marketing and sales reach for its products.
What Industry Does ALST Operate In?
Allstar Health Brands, Inc. is positioned within the expansive and dynamic healthcare sector, specifically operating in the Medical - Pharmaceuticals industry with a focus on specialty healthcare products, natural nutritional supplements, and over-the-counter (OTC) remedies. This segment is characterized by a robust and growing consumer interest in health and wellness products, driven by demographic shifts, increased health consciousness, and a preference for preventative care and self-medication. The market for nutraceuticals and OTC remedies is highly competitive, featuring numerous domestic and international players ranging from large pharmaceutical corporations to specialized supplement manufacturers. Allstar Health Brands aims to carve out its niche by leveraging specific product licenses, such as the Tapout brand, and strategic marketing partnerships, like that with WWE. While the company's market position and key product lines are not extensively defined, its operations align with the broader trend of consumers seeking accessible and natural solutions for health maintenance and minor ailments.
Who Are ALST's Key Customers?
- Consumers seeking natural nutritional supplements for general health and wellness.
- Individuals looking for effective over-the-counter remedies for common ailments.
- Customers specifically interested in pain relief products, such as sprays and wipes.
- Consumers located within the geographic regions of the Americas.
- Individuals familiar with or influenced by the Tapout brand or World Wide Entertainment (WWE) promotions.
Company Profile
Allstar Health Brands, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Toronto, CA. The company is led by CEO Peter Daniel Bagi. ALST has traded publicly since 2009.
F-Score 2/9Financial Health
Allstar Health Brands, Inc.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
ROE 8%Key Financial Metrics
Return on equity for Allstar Health Brands, Inc. stands at 7.6%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
ALST Valuation & Market Position
With a 7K market cap, Allstar Health Brands, Inc. sits in the micro-cap segment of the market. Relative to its peer group, ALST's quantitative score of 43/100 is below the peer average of 59/100.
ALST Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Allstar Health Brands' future prospects, signaling potential undervaluation.
- Positive community sentiment indicates growing belief in the company's long-term strategy and market positioning.
- Perception of Allstar as an emerging player in a growing health sector is attracting investor attention.
- Market developments suggest increasing demand for Allstar's product offerings, potentially driving revenue growth.
Bear Case
- Limited information and visibility into Allstar's operations raise concerns about transparency and risk.
- Negative community sentiment reflects skepticism regarding Allstar's ability to compete effectively in the market.
- Market perception of Allstar as a relatively small player creates doubts about its scalability and sustainability.
- Recent market developments suggest increased competition in Allstar's sector, potentially impacting market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
ALST Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
ALST Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ALST.
Price Targets
Wall Street price target analysis for ALST.
ALST MoonshotScore
What does this score mean?
The MoonshotScore rates ALST's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Peter Daniel Bagi
CEO
The provided source data does not contain specific details regarding Peter Daniel Bagi's extensive career history, educational background, or prior executive roles within the healthcare or related industries. Consequently, a comprehensive biographical profile outlining his professional journey and credentials cannot be accurately compiled from the available information. Further research would be required to ascertain these aspects of his professional background.
Track Record: Details concerning Peter Daniel Bagi's key achievements, strategic decisions, or significant company milestones directly attributable to his leadership at Allstar Health Brands, Inc. are not explicitly provided in the available source materials. Therefore, a specific track record of his impact on the company's operational or financial performance cannot be detailed within this dossier.
ALST OTC Market Information
Allstar Health Brands, Inc. is listed on the OTC Other tier, which represents the lowest and most speculative segment of the over-the-counter market. Unlike companies listed on major exchanges like the NYSE or NASDAQ, which adhere to stringent listing requirements, financial reporting standards, and corporate governance rules, companies on the OTC Other tier face minimal to no disclosure requirements. This tier is typically reserved for companies that do not meet the standards for higher OTC tiers or major exchanges, often characterized by limited public information, low trading volumes, and heightened investment risk. Investors in OTC Other securities generally have access to significantly less transparent and reliable information compared to exchange-listed companies.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lack of Transparency: The 'Unknown' disclosure status and OTC Other tier listing mean limited access to reliable and timely financial and operational information, hindering informed decision-making.
- Low Liquidity: Extremely low market capitalization and share price often result in minimal trading volume and wide bid-ask spreads, making it difficult to buy or sell shares efficiently.
- Price Volatility: Stocks on the OTC Other tier can be highly volatile due to low trading volume, limited information, and susceptibility to speculative trading.
- Regulatory Scrutiny: Companies in this tier may face less regulatory oversight, increasing the risk of fraudulent activities or non-compliance with basic business standards.
- Difficulty in Capital Raising: The lack of transparency and low market confidence associated with the OTC Other tier can significantly impede the company's ability to raise capital for growth or operations.
- Verify any available financial statements or disclosures directly from the company's website or regulatory filings, if existent.
- Research the background and track record of management, particularly given the limited public information.
- Assess the legitimacy and enforceability of key licenses and partnerships, such as the Tapout brand and WWE agreement.
- Investigate any past or ongoing regulatory actions, legal issues, or compliance concerns.
- Evaluate the company's business model and product market fit within the competitive health and wellness sector.
- Scrutinize the company's share structure, outstanding shares, and potential for dilution.
- Understand the company's operational capacity and resource allocation, especially with a small employee base.
- Founded in 1997, indicating a relatively long operational history for an OTC-listed company.
- Headquartered in Toronto, Canada, suggesting a formal corporate presence.
- Holds a specific product license (Tapout) for globally branded nutraceutical products.
- Has an established marketing partnership with a recognized entity, World Wide Entertainment (WWE).
- Operates within a legitimate and regulated industry segment (healthcare, nutraceuticals, OTC remedies).
Common Questions About ALST (Healthcare)
What does Allstar Health Brands, Inc. do?
Allstar Health Brands, Inc. is a specialty healthcare products company based in Toronto, Canada, founded in 1997. It focuses on enhancing health and quality of life by offering a range of select medicines, natural nutritional supplements, and over-the-counter (OTC) remedies across the Americas. A core part of its business involves holding the exclusive Tapout license, under which it sells globally branded nutraceutical products, including pain relief sprays and wipes. The company also maintains a strategic partnership with World Wide Entertainment (WWE) to market and sell these Tapout nutraceutical products, leveraging WWE's brand recognition to reach consumers in the health and wellness sector.
How does Allstar Health Brands, Inc. leverage its partnerships in the competitive healthcare market?
Allstar Health Brands, Inc. strategically leverages its key partnerships to navigate the competitive healthcare market, particularly through its exclusive Tapout license and collaboration with World Wide Entertainment (WWE). The Tapout license allows the company to market and sell globally branded nutraceutical products, such as pain relief sprays and wipes, benefiting from an established brand identity that can aid product acceptance. The partnership with WWE is crucial for marketing and sales, providing access to WWE's extensive global audience and powerful promotional channels. This collaboration helps to enhance brand visibility and consumer trust, which are vital for market penetration and differentiation in the crowded natural nutritional supplements and OTC remedies sector.
What are the primary risks associated with Allstar Health Brands, Inc.'s OTC listing and market capitalization?
The primary risks associated with Allstar Health Brands, Inc.'s OTC listing and market capitalization are significant. Trading on the OTC Other tier, coupled with an 'Unknown' disclosure status, means there is a severe lack of transparency and limited access to reliable financial and operational information, making informed investment decisions challenging. The company's extremely low market capitalization of 7K (approximately $5,069) and a share price of $0.0003 indicate very low liquidity, leading to wide bid-ask spreads and difficulty in executing trades without impacting the price. This micro-cap status also exposes investors to high price volatility and potential challenges for the company in raising necessary capital for growth or sustained operations, amplifying overall financial risk.
What types of products does Allstar Health Brands, Inc. offer under its specialty healthcare focus?
Under its specialty healthcare focus, Allstar Health Brands, Inc. offers a diverse portfolio designed to enhance health and quality of life. This includes select medicines, catering to specific health needs, alongside natural nutritional supplements that address general wellness and preventative health. Additionally, the company provides various over-the-counter (OTC) remedies, offering accessible solutions for common ailments. A significant portion of its product line falls under the Tapout brand, for which it holds an exclusive license. These Tapout-branded nutraceuticals specifically include pain relief sprays and wipes, targeting consumers seeking effective non-prescription options for discomfort management within the health and wellness sector.
What are the key factors to evaluate for ALST?
Allstar Health Brands, Inc. (ALST) holds an AI score of 43/100 (low). Not financial advice.
How frequently does ALST data refresh on this page?
ALST prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ALST's recent stock price performance?
Allstar Health Brands, Inc. (ALST) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Exclusive Tapout brand license for globally branded nutraceutical products. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ALST overvalued or undervalued right now?
Valuing Allstar Health Brands, Inc. (ALST) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial and operational details available due to OTC Other listing and unknown disclosure status.
- Specific market sizes and growth rates for the company's niche products are not provided in the source data.
- CEO background and track record are not detailed in the provided information.